Economic Burden of COVID-19: A Systematic Review.

Fayolah RichardsPetya KodjamanovaXue ChenNicole LiRomain SupiotLiga BennettsBrandon J PattersonBehin YektashenasMarco Mesa-FriasKrzysztof TronczynskiNasuh BuyukkaramikliAntoine C El Khoury

Published in: ClinicoEconomics and outcomes research : CEOR (2022)

The COVID-19 pandemic has generated a considerable economic burden on patients and the general population. Preventative measures such as NPIs only have partial success in lowering the economic costs of the pandemic. Implementing additional preventative measures such as large-scale vaccination is vital in reducing direct and indirect medical costs, decreased productivity, and GDP losses.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
healthcare
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
climate change
patient reported outcomes